UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD52‐negative T cells predict acute graft‐versus‐host disease after an alemtuzumab‐based conditioning regimen

British journal of haematology, 2020-10, Vol.191 (2), p.253-262

2020

Volltextzugriff (PDF)

Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

American journal of hematology, 2022-08, Vol.97 (8), p.1023-1034

2022

Volltextzugriff (PDF)

Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia

Cancer, 2022-08, Vol.128 (15), p.2922-2931

2022

Volltextzugriff (PDF)

Fertilitätsprotektive Versorgung hämatoonkologischer Patientinnen im Rhein-Main-Gebiet

Geburtshilfe und Frauenheilkunde, 2023-07, Vol.83 (7), p.790-795

2023

Volltextzugriff (PDF)

Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?

Annals of hematology, 2023-12, Vol.102 (12), p.3635-3637

2023

Volltextzugriff (PDF)

Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study

Bone marrow transplantation (Basingstoke), 2024-08, Vol.59 (8), p.1092-1096

2024

Volltextzugriff (PDF)

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison

Bone marrow transplantation (Basingstoke), 2024-05, Vol.59 (5), p.670-679

2024

Volltextzugriff (PDF)

An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease

PloS one, 2021-08, Vol.16 (8), p.e0256543-e0256543

2021

Volltextzugriff (PDF)

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

Leukemia, 2021-06, Vol.35 (6), p.1763-1772

2021

Volltextzugriff (PDF)

Veno-occlusive disease of the lung after allogeneic haematopoietic stem-cell transplantation: An autopsy study

Pathology, research and practice, 2022-03, Vol.231, p.153799-153799, Article 153799

2022

Volltextzugriff (PDF)

Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft‐versus‐host disease of the skin

European journal of haematology, 2017-12, Vol.99 (6), p.582-585

2017

Volltextzugriff (PDF)

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Blood, 2022-07, Vol.140 (4), p.349-358

2022

Volltextzugriff (PDF)

Implementation of CMV-T-Track® in Clinical Routine to Guide Management of CMV Reactivation

Blood, 2023-11, Vol.142 (Supplement 1), p.2180-2180

2023

Volltextzugriff (PDF)

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

The Lancet. Haematology, 2024-05, Vol.11 (5), p.e324-e335

2024

Volltextzugriff (PDF)

Diagnosis and grading of acute graft-versus-host disease in endoscopic biopsy series throughout the upper and lower intestine in patients after allogenic hematopoietic stem cell transplantation: a systematic approach

Leukemia & lymphoma, 2019-05, Vol.60 (6), p.1512-1521

2019

Volltextzugriff (PDF)

Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML Patients Correlates with Clinical Response and MRD Conversion

Blood, 2022-11, Vol.140 (Supplement 1), p.3410-3411

2022

Volltextzugriff (PDF)

Use of an Allogeneic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML-Patients Results in MRD Conversion, Improved Relapse-Free Survival and Vaccine Induced Immune Responses to Tumor Antigens

Blood, 2022-11, Vol.140 (Supplement 1), p.1714-1715

2022

Volltextzugriff (PDF)

Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

Bone marrow transplantation (Basingstoke), 2022-11, Vol.57 (11), p.1664-1670

2022

Volltextzugriff (PDF)

Histologic diagnosis and grading of esophageal acute graft-versus-host disease

Virchows Archiv : an international journal of pathology, 2019-03, Vol.474 (3), p.325-332

2019

Volltextzugriff (PDF)

Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion

Transplantation proceedings, 2021-05, Vol.53 (4), p.1365-1368

2021

Volltextzugriff (PDF)

Real World Results of Brexucabtagene Autoleucel for Patients with Relapsed/Refractory Mantle Cell Lymphoma - First German/Swiss Analysis

Blood, 2023-11, Vol.142 (Supplement 1), p.4394-4394

2023

Volltextzugriff (PDF)

CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2518-2518

2023

Volltextzugriff (PDF)

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Bone marrow transplantation (Basingstoke), 2023-05, Vol.58 (5), p.603-606

2023

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(49)
Berichte
(1)

Sprache

Englisch
(49)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Hematology
(23)
Humans
(18)
Oncology
(16)
Transplantation
(16)
Stem Cell Transplantation
(14)
Immunology
(13)
Adult
(10)
Aged
(10)
Middle Aged
(10)
Biophysics
(9)
Female
(9)
Hematopoietic Stem Cells
(9)
Male
(9)
Graft-Versus-Host Reaction
(7)
Hematopoietic Stem Cell Transplantation
(7)
Hematopoietic Stem Cell Transplantation - Methods
(7)
Leukemia
(7)
Leukemia, Myeloid, Acute - Therapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CD52‐negative T cells predict acute graft‐versus‐host disease after an alemtuzumab‐based conditioning regimen

Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia

Fertilitätsprotektive Versorgung hämatoonkologischer Patientinnen im Rhein-Main-Gebiet

Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?

Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison

An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

Veno-occlusive disease of the lung after allogeneic haematopoietic stem-cell transplantation: An autopsy study

Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft‐versus‐host disease of the skin

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT

Implementation of CMV-T-Track® in Clinical Routine to Guide Management of CMV Reactivation

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

Diagnosis and grading of acute graft-versus-host disease in endoscopic biopsy series throughout the upper and lower intestine in patients after allogenic hematopoietic stem cell transplantation: a systematic approach

Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML Patients Correlates with Clinical Response and MRD Conversion

Use of an Allogeneic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML-Patients Results in MRD Conversion, Improved Relapse-Free Survival and Vaccine Induced Immune Responses to Tumor Antigens

Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

Histologic diagnosis and grading of esophageal acute graft-versus-host disease

Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion

Real World Results of Brexucabtagene Autoleucel for Patients with Relapsed/Refractory Mantle Cell Lymphoma - First German/Swiss Analysis

CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Suchergebnisse filtern